PharmaTutor (April- 2014)
ISSN: 2347 - 7881
Received On: 26/02/2014; Accepted On: 03/03/2014; Published On: 01/04/2014
Author: Pradhyuman Singh Lakhawat*, Poonam Vishwakarma
Department of Management Studies,
Sam Higginbottom Institute of Agriculture Technology & Sciences,
Allahabad, Uttar Pradesh, India
pradhyuman.sngh@gmail.com
ABSTRACT:
Marketing is very important part of any organization for its existence in the market. The main strength of organization can measure on two basis first human resources and second on the basis of market share. While marketing is the major part then it should be follow the business ethical norms which are the guidelines for what is wrong and what is right in the business. But now a day’s mostly pharmaceutical in the pressure of more selling, more profit and for making the big share they are neglecting these codes. And whole pharmaceutical industry in the race of competition forgets one thing that is this marketing service is directly relate with the human life. Medicines are nectar but if it is in wrong form it can be poison for humans. So I am trying to give a small picture of current pharmaceutical marketing services and ethical codes.
How to cite this article: PS Lakhawat, P Vishwakarma, Pharmaceutical Marketing and Ethical codes: Myths or reality with special Reference to Allahabad, Uttar Pradesh, PharmaTutor, 2014, 2(4), 106-111
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Dhaval M. Dave, Effects of Pharmaceutical Promotion: A Review and Assessment, NBER Working Paper No. 18830 Issue (February 2013)
2. Wright, Robert F.; William J. Lundstrom. "Physicians’ perception of pharmaceutical sales representative: A model for analysing the customer relationship". International Journal of Medical Marketing 2004, 4 (1): 20–38.
3. Grace, Damian; Stephen Cohen Business Ethics. Victoria: Oxford University Press, 2005.
4. Pharmaceutical Association of Malaysia (PhAMA). PhAMA Code of Pharmaceutical Marketing Practices for Prescription (Ethical) Products, 2010, 18th Edition
5. Published: Guy David & Sara Markowitz & Seth Richards-Shubik, "The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation," American Economic Journal: Economic Policy, American Economic Association, November 2010, vol. 2(4), pages 1-25
6. Joan Buckley, Electronic Journal of Business Ethics and Organization Studie, 2009, Vol. 9, No. 2.
7. Mizik, N. & Jacobson, R. Are Physicians “Easy Marks”? Quantifying the Effects of Detailing and Sampling on New Prescriptions. Journal of Management Science, 2004, 50 (12), 1704-1715.
8. Manchanda, M., & Honka, E. The Effects and Role of Direct-to-Physician Marketing in the Pharmaceutical Industry: An Integrative Review. Yale Journal of Health Policy, Law, & Ethics, 2005, 2, 785-822.
9. Rod, M., & Saunders, S., The Informative and Persuasive Components of Pharmaceutical Promotion - An Argument for why the two can co-exist. International Journal of Advertising, 2009, 28(2), 313-349.
10. Connelly, D. P., Rich, E. C., Curley, S. P. & Kelley, J. T., Knowledge Resource Preferences of Family Physicians. Journal of Family Practice, 1990, 30 (3) 353-359.
.png)
